- Home
- INSE vs ACIU Comparison
INSE vs ACIU Comparison
Compare INSE & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- ACIU
- Stock Information
- Founded
- INSE 2002
- ACIU 2003
- Country
- INSE United States
- ACIU Switzerland
- Employees
- INSE N/A
- ACIU N/A
- Industry
- INSE Computer Software: Prepackaged Software
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- INSE Technology
- ACIU Health Care
- Exchange
- INSE Nasdaq
- ACIU Nasdaq
- Market Cap
- INSE 234.9M
- ACIU 189.1M
- IPO Year
- INSE N/A
- ACIU 2016
- Fundamental
- Price
- INSE $9.43
- ACIU $2.07
- Analyst Decision
- INSE Buy
- ACIU Strong Buy
- Analyst Count
- INSE 6
- ACIU 1
- Target Price
- INSE $13.50
- ACIU $12.00
- AVG Volume (30 Days)
- INSE 254.0K
- ACIU 125.1K
- Earning Date
- INSE 08-07-2025
- ACIU 08-05-2025
- Dividend Yield
- INSE N/A
- ACIU N/A
- EPS Growth
- INSE 3507.71
- ACIU N/A
- EPS
- INSE 2.43
- ACIU N/A
- Revenue
- INSE $295,200,000.00
- ACIU $32,014,254.00
- Revenue This Year
- INSE $2.61
- ACIU N/A
- Revenue Next Year
- INSE $1.52
- ACIU $533.21
- P/E Ratio
- INSE $3.88
- ACIU N/A
- Revenue Growth
- INSE N/A
- ACIU 91.20
- 52 Week Low
- INSE $6.51
- ACIU $1.43
- 52 Week High
- INSE $11.61
- ACIU $4.26
- Technical
- Relative Strength Index (RSI)
- INSE 74.46
- ACIU 55.57
- Support Level
- INSE $8.62
- ACIU $2.00
- Resistance Level
- INSE $9.77
- ACIU $2.15
- Average True Range (ATR)
- INSE 0.38
- ACIU 0.13
- MACD
- INSE 0.12
- ACIU -0.01
- Stochastic Oscillator
- INSE 90.06
- ACIU 80.92
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.